FAST International Company

Optina Diagnostics

Organization Address
7405 Transcanadienne Highway, Suite 330
Montréal (Québec) H4T 1Z2


Optina Diagnostics focuses on changing mindsets when it comes to brain health, by using the retina, the only part of the central nervous system with direct visual access, as a proxy to the brain. Through its Retinal Deep Phenotyping platform, based on its FDA 510(k) cleared hyperspectral retinal camera and image analysis algorithm, which received FDA Breakthrough Device Designation, Optina is offering an accurate, simple, and non-invasive optical test via near-patient eye clinics network. Our aim is to allow early detection of the disease’s hallmarks and a better understanding of the age-related sources of memory loss.